-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
April 28, 2017 - mHealth for Diabetes
i
Results of Topic Selection Process & Next Steps
The nominator, a managed care pharmacist, is interested in a new systematic review evaluating
the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the
Effective Health Care Program selection crit…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - These new data may
clarify any effect on mortality and gauge the comparative
effectiveness of these drugs … Additionally, combination drug therapy (using multiple
drugs with different mechanisms of action) is … In order to
5
optimize PAH care, newer information regarding the latest
drugs and combination therapies … compared a single drug (monotherapy)
with placebo or standard therapy and included the
following drugs … Drugs did not significantly differ in
their odds of causing dizziness or diarrhea.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - bleeding;; In vitro
fertilization;; Precocious puberty;; Prostate cancer
AstraZeneca
Pharmaceuticals … indications:
Endometrial hyperplasia;; Endometriosis;;
Menopausal symptom
Bayer Healthcare
Pharmaceuticals
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … It
differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
November 02, 2018 - pharmacological interventions,
and nonprescription pharmacological interventions (e.g., over-the-counter drugs … claims abound on the internet
and elsewhere about the cognitive benefits of dozens of over-the-counter drugs … Prescription Drugs Used for Treatment of CATD Cognition, Function, Quality of Life or BPSD
Class of … inhibitors, NMDA antagonists,
KQ 4-6: For targeting BPSD and quality of life outcomes:
Prescription drugs … Since this outcome eliminated, drugs targeted to these
symptoms should be eliminated.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-update_research-protocol.pdf
December 04, 2015 - that is currently available in the United States; we will assess the evidence for
all uses of these drugs … We will search for clinical study reports from the European
Medicines Agency, and search Drugs@FDA for … We will revise the inclusion/exclusion form from the
original review (e.g., add conditions and new drugs … However, such an approach does not allow for comparisons between drugs that may not have
much direct … evidence (e.g., drug A has been compared to drug B and C, but drugs B and C have
not been directly
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With
Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use
of One or More Antihypretensive Drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
May 01, 2013 - CER #9:
Comparative Effectiveness of Percutaneous Coronary
Interventions and Coronary Artery Bypass Grafting
for Coronary Artery Disease
Original release date:
October 2007
Surveillance Report:
May 2013
Key Findings:
- New RCT and cohort studies further delineate which
patients have improved outcome…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-updates_methods.pdf
July 01, 2011 - evidence-based-policy-
center/derp/index.cfm), has conducted SRs of comparative effectiveness and safety for drugs … then key questions for potential modifications are assessed to accommodate
new evidence (e.g., new drugs … These
developments include new controversies, drugs or devices in development, ongoing trials and … across EPCs
across the range of health care interventions and treatment modalities (e.g., devices,
pharmaceutical … products, surgery, diagnostic tests, and other procedures) is needed.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (…
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is
part of AHRQ’s Effective Health Care program. It is a collaborative network of research
centers that support the rapid development o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - Each class of drugs is given own paragraph except statins and
fibrates are combined. … statins with different
lipid-modifying drugs are compared with ?higher-dose? statins. … richness in
the potential benefits of other permutations of co-administering other lipid-
modifying drugs … not meet treatment targets could benefit greatly from the co-
administration of other lipid-modifying drugs … The way it is now, some outcomes are not reported for some
drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - the Food and Drug Administration and as
described in the prescribing information for the above cited drugs … Prescribing information for these drugs may be obtained from
www.astrazeneca-us.com or by calling the … Recommend the following language:
“When used in pregnancy during the second and third trimesters,
drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - whereby the concentration of a
drug is greatly reduced before it reaches the systemic circulation) of drugs … Chemoembolization
drugs and embolic
mixtures have also
changed a great deal in
the last ten years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - Drugs 2009;69:137-150. PMID: 19228072. … Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT. 2016
10.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
March 01, 2013 - combined functional outcomes measured on different
scales in placebo-controlled studies of Alzheimer’s drugs … and large referents,34 the clinical
significance of the additional treatment effect of Alzheimer’s drugs … Enhanced persistence with
tiotropium compared with other respiratory
drugs in COPD. … Drugs Aging.
2007;24:155-67.
34. Cohen J.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
January 28, 2019 - analgesics, including ketamine, nitrous oxide/oxygen, acetaminophen, and non-steroidal
anti-inflammatory drugs … prehospital analgesia, issues pertaining to
emergency medical services (EMS) personnel who administer the drugs … Abbreviations: KQ=key question; NSAIDs=nonsteroidal anti-inflammatory drugs; PICOTS=population,
intervention
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - Formulary Committee Neurology and
Psychiatry Task Force, responsible for making decisions on which drugs … therapy (specifically, they were
asked to simulate a decision in which they are trying to choose which drugs … Explicit description of the intervention (dosing, duration, delivery,
manpower, trade names of drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … It differentiated 100%
of multiple drugs and doses taken simultaneously by type and by dose.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
March 10, 2010 - General Comment: On behalf of Novartis Pharmaceuticals Corporation
(Novartis), we are pleased to provide … Appendix Appendix C tables: for all tables, please include the target dose for
the drugs featured in
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - literature
database, the Cumulative Index of Nursing and Allied Health Literature (CINAHL), the
EMBASE Drugs … , subject headings, and a combination of subject
headings and/or key words (e.g., phenylketonuria, pharmaceutical … preparations, dietary
therapy).